Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
6.89
+0.27 (4.08%)
At close: Nov 7, 2025, 4:00 PM EST
6.96
+0.07 (1.01%)
After-hours: Nov 7, 2025, 7:51 PM EST
Immuneering Market Cap
Immuneering has a market cap or net worth of $435.71 million as of November 7, 2025. Its market cap has increased by 580.26% in one year.
Market Cap
435.71M
Enterprise Value
413.36M
1-Year Change
580.26%
Ranking
Category
Stock Price
$6.89
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has increased from $365.84M to $435.71M, an increase of 19.10%. That is a compound annual growth rate of 4.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 435.71M | 537.84% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |